verified SJR 1,742 · Q1 • database Scopus / SJR & Web of Science indexed

United Kingdom · Elsevier Ltd

workspace_premium Q1 — Drug Discovery lock_open Open Access Unclaimed

Drug Discovery Today

Drug Discovery Today is a journal indexed in SJR in Drug Discovery and Pharmacology with an H index of 226. It has a price of 2395 €. It has an SJR impact factor of 1,742 and it has a best quartile of Q1. It is published in English. It has an SJR impact factor of 1,742.

Drug Discovery Today focuses its scope in these topics and keywords: drug, discovery, library, drugs, development, clinical, cancer, challenges, binding, biology, ...

ISSN: 1359-6446

Editorial: Elsevier Ltd

Category: Drug Discovery

Indexation: verifiedScopus / SJR verifiedWeb of Science

Unclaimed profile — some fields may be incomplete.

open_in_new Portal NPD menu_book Guidelines NPD

schedule Datos CoP · solo campos en BD

SJR Impact Factor trending_up

1,742 Q1

H-index 226

Tasa de Aceptación pie_chart

20% Selectiva

Fuente Acceptance_Rate

Tiempo a publicación hourglass_top

NPD

Campo Sin dato

Coste de Publicación (APC) payments

2.395 € Open Access

Ruta Non-OA 0 €

Metrics

Campos Scimago / CoP — sin series inventadas

Scopus / SJR Web of Science

SJR Impact

1,742

H-index

226

Docs (year)

278

Docs 3y

854

Total refs

22995

Cites 3y

7067

Citable 3y

821

Cites/Doc 2y

7.83

Ref/Doc

82.72

Immediate OA

2395 €

Embargoed OA

NPD

Non OA / Submission

0 €

shield Researcher voice

Name good journals. Call out predatory ones.

Share what peer review, fees, and timelines were really like. Praise fair editors. Flag APC traps, fake metrics, or spam solicitations — with facts from your submission.

Fair & fast peer review Clear APC / no surprise fees Suspected predatory Fake impact claims

rate_review Write an honest review

Researcher reviews

sentiment_dissatisfied No reviews yet — be the first to share an honest experience.

Publication speed *

Review quality *

Edition and editorial team *

Institutional email or ORCID * * Only to validate authenticity — identity is not shown publicly.

Best articles by citations

Combinatorial approaches to chemistry and biology

Working with worms

Diversa and diversity

Design and discovery of neuropeptide Y1 receptor antagonists

Could insulin protect against atherosclerosis?

Corporate intelligence in biotechnology

Comparison of some major information resources in pharmaceutical competitor tracking

Combining drug-disease and economic modelling to inform drug development decisions

Combinatorial chemistry

SHOW MORE ARTICLES

Combinatorial chemistry

Antimalarial Chemotherapy: Mechanisms of Action, Resistance and New Directions in Drug Discovery

CombiChem deal

Chiroscience/BMS MMP inhibitor progress

Chiral Europe '95

Chemokines and their receptors

Challengeability of biotechnology patents in the light of Biogen v. Medeva

Cell signaling: signal transduction and gene transcription

Can you stand the heat of today's drug discovery?

Bilosomes: the answer to oral vaccine delivery?

Beating superbugs with the Gulliver effect

Antisense Drug Technology: Principles, Strategies, and Applications

FAQS

In Country of Papers you can find SJR impact factor and other metrics to help you decide on a Journal.